Excessive snoring is a comm on problem that isfrequ ently treated surgically. In the early I 980s, uvulopalatopharyngoplasty was introduced to the United States as the fi rst surgical treatment f or excessive snoring. It remain s in common use, but its limitations created an incenti ve to develop a pro cedure that is as effec tive, but safer and more economical. Several other surgical procedures fo r snoring we re dev el op ed, in cluding la ser-a ssist ed uvulopalatopla sty, palatal stiffening ope rations, and radiofrequ ency ablation. Each ofthese procedures has its own ad vanta ges and limi tati ons; which pro cedure is the best treatm ent for exce ssive sno ring is controversial. We present our expe rience with each of these pro cedures, along with a thorough review ofthe literature, to help the otolaryngolo gist determin e which is the best snoring surgery fo r the individual patient.
Introduction
Snoring is a significant social prob lem that is commonly managed by the otolaryngologist. Approximately 20% of all adu lts-including nearly 50% ofthose over 60 years of age-are chronic snorers.' Snoring is the hallmark symptom of a spectrum of sleep-related breathing disorders collecti vely termed sleep disordered breathing.The pathophysiologic cause of sleep disordered breathing is sleepinduced airway obstruction. Minim al airway obstruction causes primary, or simple, snoring. On the other extreme, complete airway obstruction causes obstructive sleep apnea syndrome (OSAS).
OSAS traditionally receives more attention than does snoring becau se of its well-documented influence on mortality. It is now evident that untreated snoring also has medic al implications, especially in some snorer s who do not have OSAS but who manifest exce ssive daytime sleepiness (EDS). 2 In these patient s, an elevated degree of airway resistance causes sleep fragmentation and EDS , but without the obstructive episodes of OSAS . The identification of this group resulted in the recognition of a new syndrome, intermediate between primary snoring and OSAS, called upper airway resistance syndrome? Patients with this syndrome benefit from appropri ate treatment.
The proper management of snoring begins with conservative measures that decrease airway resistance. Cons ervative therapy includes exercise, weight loss, decreased alcoho l con sumption, smoking cessation , altered sleeping position, and denta l or nasal appliances . Although these measures often provide some benefit, patients generall y do not obtain sufficient relief from their snoring. For this reason, surgery is the preferred treatment."
Because exces sive snoring is so common, there is an incentive to find a simple, safe, effective, and economical surgical remed y. Many procedures were developed during the past 2 decad es, but which procedure, if any, is preferable is controversial. No single procedure has been proven to have the ideals that ju stify its sale use over others.
Our purpo se is to review the snoring literature and to provide an objective overview of the four primary type s of procedures now in use. Although some snoring surgeries are also used to treat OSAS, our intent is not to assess their merit s in OSAS. OSAS is mentioned only when clinic al issues make it relevant.
Although we primarily address palatal procedures, the airway obstruction that produces snoring can occur at several sites . The anatomic areas most often implicated in The reasons for this decline in efficacy are not entirely known. The decrease in long-term success rates might represent a true increase in the incidence of snoring, or it might merely be a reflection of inexact measurements. Unfortunately, there is no standard way to measure the intensity of a patient's snoring. Nearly all researchers rely on the subjective assessment of the patient' s bed partner, and they use one of several scale s to quantify the inten sity of snoring. Attempts to objectively quantify intensity have met with only limited success.":'? For now, snoring is "in the ears of the beholder," because its capacity to irritate involves more than just decibels."
Another problem is that there is little agreement on what constitutes a successful outcome. Some authors define success as "improved to absent snoring," while othe rs call it "absent or markedly reduced snoring." Using the former definition will interject bias into a study toward a better outcome, as is evident in the literature.
Until these issues are resolved, it will remain difficult to quantify the true outcome of UPPP or any other snoring procedure. Nonetheless, in the largest long-term UPPP study to date , only 46 % of patients said that they had stopped snoring or that their snoring was markedly improved (i.e., their bed partner was infrequently awakened)." There is little doubt that many UPPP patients do not obtain adequate relief of their snoring. The new procedure quickly became the gold standard. In the technique described by Fujita, the patient undergoes a tonsillectomy, which is followed by a partial removal of the soft palate , uvula , and pharyngeal arches (figure 1). Finally, the mucosal edges are approximated with sutures. The procedure is performed under general anesthesia. The intended effect is to lessen snoring by allowing more room for airflow and by reducing vibratory tissue.
Early results indicated that UPPP was 75 to 100% effective in eliminating or significantly reducing snoring.P'" This was most encouraging, but as these patients were followed , it became apparent that the long-term success rates were not as good, ranging from 46 to 73 %.14. 16 Koay snoring are the retropalatal pharynx and retrolingual pharynx." Several surgical procedures are Procedure available to correct each type of snoring, but the retrolingual procedures are more invasive and complicated than the palatal procedures. Nasal surgeries, such as septoplasty and inferiorturbi-Anesthesia nate resection, rarely provide relief from snoring when used No. sessions alone." They are best used as an adjunct to more definitive surgi-Pain cal procedures. For these rea-Cost sons , most patients who desire surgical treatment are initially Anatomic site Palatopharynx offered a palatal procedure.
Palatine tonsils Several surgical procedures performed to treat retropalatal snoring are common, while others are more novel. Many procedures have similarities with others . For this review, we placed each procedure into one of four general categories: uvulopalatopharyngoplasty, laserassisted uvulopalatoplasty, palatal stiffening operations, and radiofrequency ablation (table). Based on our clinical experience with all of these procedures, we describe the advantages and limitations of each, and we offer clinical pearls that pertain to each technique.
SNORING SURGER Y: WHICH ONE IS BEST FOR YOU?
In addition to relieving snoring, UPPP alleviates EDS. In one long-term study of 5 1 patients who initially complained of EDS, 73% later said that their EDS had been completely or markedly allevia ted."
Few studies have specifically addressed UPPP ' s complications. Of the four major studies that did, all includ ed patients with OSAS, and only three estimated the prevalence of any complications. Of these three studies, the two largest were retrospective, while the other was a smaller prospective series. The most serious perioper ative complication was a 2 to II % incidence of postope rative airway obstruction that resulted in an approximately 1% perioperative mortality.i' :" One group reported a 5% incidence of difficult intubation, but they correlated that incidence to the severity ofOSAS . 21 Postoperative bleeding serious enough to require a return to the operating room occurred in 2 to 5% of cases." :"
Clinic al experience indicates that UPPP is often complicated by severe postoperative pain. Few studies have attempted to quantify this. In one series, 86% of patients were satisfied with the outcome of their procedure , but in retrospect, because of the pain, only 60% said they would undergo the same treatment ."
The most common lon g-te rm complic ations are velopharyngeal incompetence (VPI) and palatal dryness. Temporary postoperative VPI occurs in most patients , and studies have reported that 10 to 24% of patients continued to complain of intermittent nasopharyngeal regurgitation 1 year after surge ry." :" In the same studies, up to 31% of patients compl ained of persistent palatal dryness.F:" Less frequent long-term complications include nasopharynge al stenosis, long-term voice change s, and a partial loss of taste. 22 ' 24 In addition to all its limitations, UPPP is expen sive . Costs vary widely among institutions, but the procedure, the anesthesia, and I night of postoper ative monitoring in an intensi ve care unit can cost in exces s of $ 10,600. 6 Laser-assisted uvulopalatoplasty The limitations of UPPP created a demand for a more effective, safe, economic al, and comfortable alternati ve. In 1986, the French surgeon Kamami used a CO 2 laser for a procedure initially called laser vaporization of the palatopharynx . It was similar to the standard UPPP except that the tonsils were not remo ved, and it was performed in several stages under local anesthesia. Kamami ' s • Hypo-allergenic: The SinuCleanse system contai ns no latex and is safe for use in patients with latex allergy.
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For more information Circle 117 on Reader Service Card initial results, published in 1990, were encouraging, as the short-term success rate was 97%.25 Coleman introduced the procedure to the U.S . in 1992, but by then it had been modified and was called the laser-assisted uvulopalatoplasty (LAUP). 26 The most popular LAUP technique was described by Krespi and Keidar in 1994. 27 A CO 2 laser with a special backstop attachment is used to make vertical throughand-through incisions on both sides of the uvula. These incisions form trenches that extend 1 to 2 em from the free edge of the velum. The uvula is then shortened significantly (figure 2). The entire procedure is performed under local anesthesia and is repeated in 4 to 6 weeks as necessary.
Short-term data indicated that LAUP either eliminated or significantly decreased snoring in 70 to 97% of patients . 25 ,28-33Two clinical trials directly compared LAUP with UPPP, and both failed to show any significant difference in short-term efficacy between the two procedures." >' LAUP also appeared to alleviate EDS, as 72% of patients who had EDS reported either a diminution or elimination of their symptoms."
As happened with UPPP , it was feared that these optimistic short-term results would deteriorate with longer follow -up . 'Kamami reported in his own series of 741 864 patient s that "after several months .. .snoring had reappeared in a few cases , but [it was] much less disturbing than before.'?' The first research to specifically address this issue indicated that the efficacy of LAUP did decrease over time." At 18 to 24 months after surgery, only 55 % of patients reported that their bed partner was satisfied with the outcome. As with the UPPP data, LAUP studies are difficult to interpret because of nonstandardized measurements and subjective reporting.
LAUP is less invasive than UPPP. LA UP requires less palatal resection, and it does not remove the tonsils . Unlike UPPP, it is performed under local anesthesia. These differences should result in fewer postoperative complications, especially bleeding and airway obstruction. The less-extensive palatal resection should also mean fewer longterm complications such as VPI and voice changes. Clinical experience confirms this to be true . In the largest study of LAUP complications to date, Walker and Gopalsami prospectively followed 275 patients who had undergone 754 procedures." They found that 1.3% of patients experienced postoperative hemorrhage that required medic al treatment, 0.5% had a local infection, 0.5% had temporary VPI, and 0.3% had a temporary loss of taste. There were no cases of airway compromise or death and no longterm VPI, nasopharyngeal stenosis, or voice changes. Smaller studies reported similar complication rates, although the incidence of temporary VPI has been reported to be as high as 3%. 33 There have been no reports of death or permanent nasopharyngeal stenosis secondary to LAUP.
Although LAUP is generally associated with fewer complications than UPPP, postoperative pain is the one exception. Both of the clinical trials that directly compared LA UP with UPPP showed no significant difference in postoperative pain between the two procedures." :" Postoperative pain peaked anywhere from 3 to 9 days after surgery, and it usually resolved within 2 weeks of surgery.P-" Severe pain from LA UP negatively affects patient compliance. 32, 33 In one report, 77 % ofpatients who abandoned their therapy early cited severe pain as the most important reason ." Also , unlike UPPPpatients, who undergo the procedure only once, LA UP patients must endure the postoperative pain several times. The number ofprocedures needed varies, but most patients require two to four sessions. 25.26.28.29.32 Another disadvantage is that LAUP is difficult to perform on patients who have a strong gag reflex.
Enthusiasm for LAUP rapidly proliferated throughout the U.S., and as a result, the procedure started being used to treat OSAS, even though there were concerns that there were not enough data to support its use for this condition. Further reports on the indications for LAUP created confusion and controversy. In 1996, Lauretano et al reported that OSAS was actually worse in some patients following LAUP.37 Research also raised a theoretical concern that although LAUP can eliminate snoring, it might exacerbate the underlying pathophysiology of OSAS, even in patients with only primary snoring." LAUP could alleviate a patient's symptoms, but it could also lead to worse obstructive disease.
This concern was confounded by evidence that showed that untreated OSAS is a progressive disease." Many patients who developed further airway obstruction after Volume 78, Number 11 LAUP might have been even worse if they had not undergone the surgery. Currently, the American Sleep Disorders Association does not recommend LAUP for the treatment of either snoring or OSAS . If LAUP is desired, the association recommends that the preoperative evaluation of each patient include an objective measurement of respiration during sleep to rule out OSAS. 40 Near the time Kamami pioneered LAUP, the Swedish surgeon Carenfelt described a similar technique." To perform his procedure, which he called laser uvulopalatoplasty (LUPP), Carenfelt used a CO 2 laser to resect the palatal tissue, much like UPPP does . LUPP was performed in one stage just like UPPP, but it required only local anesthesia. The short-term results ofLUPP were similar to those of UPPP,41,42 but it never became as widespread as UPPP and the staged laser techniques.
Other variations of the LAUP technique include Nd:YAG LAUP, cautery-assisted uvulopalatoplasty, and cold-steel uvulopalatoplasty. Each of these techniques uses different cutting instruments to perform essentially the same procedure. Data evaluating these procedures are limited, but so far they indicate that these variations pro-duce results similar to those of the standard LAUP. [43] [44] [45] [46] The disadvantage of LA UP is that the tonsils are not removed. Krespi and Ling described a laser-assisted serial tonsillectomy that can be performed concurrently with LAUP, but their procedure is not in widespread use." The more common approach is to perform UPPP on patients who have tonsillar hypertrophy and perform LAUP on those who do not ."
Overall, the results of LA UP are comparable with those ofUPPP, but they can be obtained at a fraction ofthe cost. " A national newspaper recently estimated that the cost of LAUP is only $1,500 to $2,000. 48 This figure does not include the additional cost of a sleep study.
Palatal stiffening operations
Concern over the morbidity caused by UPPP and LAUP led to a search for a technique that is simple and minimally Antibiotics at the crossroads How to overcome resistance
So many pathogens, such ingeniousdefenses
Resistant organisms are those that will not be inhibited or killed by an antibacterial agent at concentrations of the drug achievable in the body with normal dosage. "Bacteria confronted with something that's going to kill them are either going to get killed or they are going to survive," according to Stuart B. Levy, MD, Professor of Medicine and Director ofthe Center for Adaptation Genetics and Drug Resistance at Tufts University. "The surviving ones have developed a means to curtail, destroy, run around the antibiotics.'"
B -Iactamasesthe most problematic resistance mechanisms
Antibiotic inactivation occurs through several basic mechanisms. The most common resistance mechanism is the production of beta-Iactamase enzymes that destroy the antibiotic. Beta-Iactam Penicillins B-Iactamase-mediated-inactivation of penicillin antibiotics-most of which are either penicillins or cephalosporins-have a beta-Iactam ring that is essential to their activity, the inhibition of bacterial cell wall synthesis. Bacterial genes encoding beta-Iactamases, which break the beta-Iactarn ring, have been found in both gram-positive and gram-negative bacteria. The activity ofbeta-Iactamases is variable; some are highly active against penicillins, others against cephalosporins, others against both groupS.2. 3 One strategy for circumventing beta-Iactamase-mediated resistance has been to combine the beta-Iactam drug with a molecule sometimes referred to as a "suicide inhibitor."4 These molecules bind with the betalactamase, preventing it from inactivating the antibiotic. Unfortunately, there are many classes of beta-Iactamase, and the inhibitors do not bind with all of them. No beta-lactarn drug or beta-Iactamase inhibitor can resist all of these enzymes. 2 . 3
Altered antibiotic targets
A second resistance mechanism involves modification of the antibiotic target site in the bacterium, so that the drug no longer binds. An alteration in penicillin-binding sites is the mechanism by which Streptococcus pneumoniae (a common respiratory tract pathogen) has become resistant to penicillins and to some cephalosporins. 5 Alterations in antibiotic target sites can occur through spontaneous mutation of a bacterium's own genetic material , acquisition of DNA from another bacterium, and acquisition of DNA fragments, known as plasm ids, which can travel from one type of bacterium to another.'
Permeability alterations + active efflux
A third mechanism of resistance is the alteration by gram-negative bacteria of their outer membrane transport channels that serve as the bacterium 's own transport system , and which also allow the antibiotic to enter the organism. 2 ,3 This is accomplished by mutations of genes encoding the outer-membrane protein channels called ponns.eBecause the transport systems are essential to bacterial viability, this mechanism of resistance is weak. and may sometimes be overcome by increasing the antibiotic dose. However, in combination with other resistance mechanisms, decreased permeability can result in resistance that cannot be surmounted by increased antibiotic dosage. 3 Some bacteria are also able to pump antibiotics and other toxins out of the cell faster than they can accumulate by diffusion or active influx, a mechanism referred to as "active efflux." The slow influx of antibiotic through the low-permeability outer membrane. along with the efficient efflux of drug. can result in high-level resistance because the organism is able to survive and mutate in the presence of the antibiotic. 2 ,3 
Resistanceagrowing challenge
Infections caused by antibiotic-resistant organisms area growing part of clinical practice. Resistance can produce therapeutic failure, and carries a risk of fatal in a series of three outcome. National surveillance systems are beginning to monitor and publicize the emergence of resistance to current antibiotics.s Increasing microbial resistance clearly demonstrates that the fight against infection is far from over, and that new, highly effective antibiotics are needed. invasive and th at doe s not inte rfere with norm al velopharyngeal function. In 1993, Elli s et al used a mechanical model to demonstrate that stiffening the soft palate, rather than shortening it, can redu ce the "palatal flutter" of snoring." They proposed indu cin g scar form ation by using an Nd :YAG lase r to re move a longitudinal strip ofpalatal mucosa, while lea vin g the velum and uvul a intact. The short-term result s of their ser ies of 16 laser palatoplasty patients were similar to those of UPPP studies , but complications we re only minim al.
Ingrams et al used a laser to perform a palatopl asty similar to Ellis's techniqu e except th at they used a CO 2 laser and amputated the uvula." Their results were co mparable. Clarke et al adopted the palatal stiffening co ncept, but abandoned lasers in favor of electroca utery.34 In the ir randomized, controlled trial on 62 patients, they sho wed that there were no significa nt differences in 6month efficacy between ca utery palatoplasty, laser palatoplasty, and UPPP. Caut ery palatopl asty and laser palatoplasty caused significa ntly less short-ter m VP I. Postoperative pain wa s similar in all three gro ups.
Another development was the caut ery-a ssisted palatal stiffening operation (CAPSO), in wh ich the surgeon uses electrocautery to remove a longitudinal strip of muco sa along the soft palate and the anterior uvul a ( figure 3) . A recent series of206 CAPSO patients sho wed a 92% shor tterm success rate (defined as a patient rep ort that snor ing is no longer a problem ) and a 77 % success rate at 12 months." There were no intraop erative co mplications . Postoperati ve complications included bleeding (1%), temporary VPI « 1%), and temporary xeros to mia or taste changes (1 %) . There was no ev ide nce of nasoph aryng eal stenosis, wound infection, or voice ch anges. Odynophagia was notable during po stop erative day s 3 through 10, with peak intensity on day s 5 to 7. Th e pain had usually resolved by postsurgical day 12.
Palatal stiffening procedures have adva ntages over their predecessors. Th e data now ava ilable show that their short-term effi cacy is similar to those of UPPP and LAUP. The minimal invasiven ess of these pro cedures should mean fewer complications than with the previou s procedures, a belief th at is supported by the lim ited data previously described.
Palatal stiffening procedures are also mo re con veni ent and more economical than their predecessor s. Each pal atal stiffening is performed during a single outpatie nt visit under loc al anesthes ia. An added adva ntage of the electrocautery procedures is that they do not require expe nsive and cumbersome laser equipme nt. Costs vary amo ng institutions, but our ex peri ence shows that CAPSO cos ts about $150, which is about 10 tim es less ex pensive than complete tre atment of snori ng with LAUP and mor e than 70 time s more economical than UPPP with ove rnight intensive care.
Radiofrequency ablation
Re centl y, Powell et al used a custom-fa brica ted electrode to deliv er radiofrequency energ y to the so ft palate (figure 4).52 Th e prim ary obj ectiv e of their ex peri me nt was to d et e rm in e th e safe ty of t he pro c e du re-c all ed radiof requency ablation (RFA) or somnoplasty (So mnus Medical Techn ologies Inc.; Sunnyvale, Calif.)-because radiofrequency energy is rarely used in the upper airway . In their prospective, nonrandomized study, 16 patients reported a mean 77 % decrease in snori ng after three or four procedu res. Th ere were no maj or co mp lications. Th e most co mmo n min or co mplication was erosion of the palat al surface mucosa 2 to 4 days afte r treatm ent. Complic ation s reported in an oth er study of 18 pati ent s included two cases of uvular sloughing and one case of a submucosal fistula."
Th e adva ntage that RFA has over UPPP and LAUP is that it is min imally invasive, whic h impl ies fewe rcomplica tio ns. It induces palatal stiffening by sca rri ng palatal muscle, but it nor ma lly leaves the palatal mucosa unaffec ted. Th is sho uld make RFA significa ntly less pain ful than any other snor ing procedure.
Li ke LAUP and the palatal stiffening procedu res, RFA is performed und er local anes thes ia. Unfortunately, unlike the palatal stiffe ning procedures, RF A requires the patient to undergo several treatment sessions. Care must be taken to insert the needl e directl y into the palatal muscle, because superficial place me nt leads to mucosal slough ing. Also, because the needl e is ex tended into the palate wit hout direct visualization, the needle might be placed inadvertently th rough the palate into the nasoph arynx . RFA req uires ex pensive equipment , includ ing a radi ofrequ en cy ge nera tor and disp osabl e handpieces. Overall , a co mplete RFA of the soft palate costs around $2, 500. 54 Th e applica tions of RFA are ex pand ing . We find it useful for turbi nate and base of the tongue ablation for treating snori ng and OS AS ,55.56although we have experienced complica tio ns, including ton gue base abscesses. RFA has a distinct advantage over other snori ng procedures because it is the only outpatient snor ing procedure that addresses snoring from seve ral anato mic sites . RFA is prom ising, but unt il it is co mpared directl y w ith other snoring treatments, its adva ntage s will re main unp roven.
Discussion
Th e otolary ngo log ist should custo mize pa latal snor ing surgery in accordance with the patient ' s ana to my, the patien t' s social and fina ncia l co ncerns, and with his or her ow n practice param eters. Ou r current clinica l practice uses all four major surgica l tec hniq ues to various degrees. Each procedure ca n have a place in the cli nical prac tice of today' s oto lary ngo log ist. UPPP has adva ntages for the snorer with a redundant posteri or ph aryngeal wa ll or large For in fo rmati on o n ad vertise me nt s , p roduct s o r se r vices in thi s issu e, s im p ly f ill in th e card , circle th e ap propr ia te n u m be rs an d d rop it in th e m a il... or fax it now to 216-522 ·9 707. I  I  I  I  I  I   i   I  I  I  I  I  I tonsils." LAUP is attrac tive for compliant patients with large posterior tonsillar pillars when laser equipment is readil y ava ilable. RFA should be consi dered for compliant patient s when a radiofrequency generato r and disposable handpieces are ava ilable. Pain is minimized when mucosal ulcer ation does not occur. RFA is also under investigation for use in newer applications, including turb inate and tongue base ablation for snoring and OSAS . The palatal stiffening operations are performed durin g a single office procedure under local anesthesia, and the palat al procedures that use electrocautery are performed with minim al expense.
We have not mentioned eve ry procedure that is used to treat palatal snoring. Uvulectomy has been attempted, but its short-term results were poorer than those of other procedures." In addition, newe r procedure s are under investig ation , including ones that induce palatal stiffening by injecting sclerosing age nts into palatal tissue."
It should be emphasized that the procedures discussed in this article address palatal snoring exclusi vely, and they make up only one comp onent of the managem ent of the snor ing patient. All patient s who complain of snori ng should attempt conserva tive thera py first because it is simple, safe, and part of a health y lifestyle. Surgery for snoring is rationally perform ed in a stepwise manner, usually beginn ing with procedu res that address palat al snoring and, if nece ssar y, progressing to procedures that correc t oth er levels of airway obstruction."
All procedures are discussed here in the context of treating snoring, not OSAS . It is wise to ensure that any snoring patient does not have OSAS before the surgeon attempts any surgical procedure. Every patient should have some type of objective measurement of sleep respiration. Just how extensive this screening should be is a controversial matter, so the decision is generally left to the clinical judgment of the otolaryngologist.
A numb er of techniques have been described to improve patient selection for snoring surgeries. Obj ecti ve measurem ents such as the Muller maneuver and sleep nasoendo scopy attempt to identi fy palatal snorers, but the reliability of each of these procedures has been brou ght into question.P-" More recentl y, acoustic analysis of oro nasa l respiration (SNAP testing) has shown prom ise as a technique to identify the low frequency of velum-like snoring."
Studies remain difficult to interpret because of the lack of standardized methods to report snoring outcomes. Several promising measurement techn iques are now used. Th e subjective recording of surge ry outcomes on a standardized visual analog sca le is the most prominent of the new techn iques, and its use will lessen some of the confu sion .
Alth ough we categorized each snoring procedure by the specific technique and mod ality, all of these proc edures Volume 78, Number 11 have important similarities. The traditional emphasis (especially with UPPP) is on increas ing pharyngeal airspace. However, the clinical effec t of each procedure might be prim arily the result of palatal scarri ng. If palatal scarring is the common denomin ator of all snoring surgeries, it is logical to use techniques that induce as much scarring as possible without unnecessarily disturbin g velopalatal function. CAPSO and RFA are ideal in this situation.
